An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: potential therapeutic use in autoimmune diseases. (Q53179365)
Jump to navigation
Jump to search
scientific article published on 17 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: potential therapeutic use in autoimmune diseases. |
scientific article published on 17 March 2012 |
Statements
An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: potential therapeutic use in autoimmune diseases. (English)
Zhong-Tian Xue
Hans-Olov Sjögren
Leif G Salford
Bengt Widegren
17 March 2012
51
2
101-111
1 reference